PHASE 3 TRIALS OF PORT DELIVERY SYSTEM WITH RANIBIZUMAB IN PATIENTS WITH DIABETIC RETINOPATHY (DR) WITH OR WITHOUT DIABETIC MACULAR EDEMA (DME)

被引：0
|
作者：
Cooper, B. [1 ]
Chang, M. [2 ]
Smith, R. [3 ]
Malhotra, V. [3 ]
Latkany, P. [3 ]
机构：
[1] Retina Associates LLC, Ophthalmol, Lenexa, KS USA
[2] Retinal Consultants, Ophthalmol, Sacramento, CA USA
[3] Genentech Inc, Ophthalmol, San Francisco, CA USA
来源：
DIABETES TECHNOLOGY & THERAPEUTICS | 2022年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
EP249 / #4
引用
收藏
页码：A185 / A185
页数：1
相关论文
共 50 条
  • [41] Port Delivery System with ranibizumab (PDS) met primary endpoint and key secondary outcomes with > 75% of patients preferring PDS treatment in phase 3 Pavilion trial for diabetic retinopathy (DR)
    Latkany, Paul
    Regillo, Carl
    Wykoff, Charles C.
    Chang, Margaret
    Emanuelli, Andres
    Holekamp, Nancy
    Malhotra, Varun
    Howard, Dena
    Santhanakrishnan, Anjana
    Wetzel-Smith, Monica
    Quezada-Ruiz, Carlos
    Pieramici, Dante Joseph
    Latkany, Paul
    Regillo, Carl
    Wykoff, Charles C.
    Chang, Margaret
    Emanuelli, Andres
    Holekamp, Nancy
    Malhotra, Varun
    Howard, Dena
    Santhanakrishnan, Anjana
    Wetzel-Smith, Monica
    Quezada-Ruiz, Carlos
    Pieramici, Dante Joseph
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
  • [42] Baseline predictors of functional outcomes in patients with diabetic macular edema (DME) in the RISE and RIDE trials
    Sophie, Raafay
    Lu, Na
    Campochiaro, Peter A.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [43] The top 10 findings from the RIDE/RISE trials of ranibizumab in patients with diabetic macular edema
    Singh, Rishi P.
    Tuomi, Lisa
    Stoilov, Ivaylo
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [44] Proliferative Diabetic Retinopathy Events in Patients With Diabetic Macular Edema: Post Hoc Analysis of VISTA and VIVID Trials
    Do, Diana, V
    Gordon, Carmelina
    Suner, Ivan J.
    Reed, Kimberly
    Moini, Hadi
    Gibson, Andrea
    Du, Weiming
    Shah, Chirag P.
    JOURNAL OF VITREORETINAL DISEASES, 2022, 6 (04) : 295 - 301
  • [45] Macular Ischemia Changes in Patients with Diabetic Macular Edema Treated with Aflibercept and Ranibizumab
    Maris, Dimitrios
    Dastiridou, Anna
    Kotoula, Maria
    Karathanou, Aikaterini
    Tsironi, Evangelia E.
    Bargiota, Alexandra
    Androudi, Sofia
    DIAGNOSTICS, 2024, 14 (12)
  • [46] THE ECONOMIC IMPACT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION (NAMD), DIABETIC RETINOPATHY (DR), AND DIABETIC MACULAR EDEMA (DME): A SYSTEMATIC LITERATURE REVIEW OF THE EMERGING LITERATURE
    Willmington, C.
    Murphy, A.
    Kirby, A.
    VALUE IN HEALTH, 2024, 27 (12) : S130 - S130
  • [47] Prophylaxis of Macular Edema with Intravitreal Ranibizumab in Patients with Diabetic Retinopathy after Cataract Surgery: A Pilot Study
    Udaondo, Patricia
    Garcia-Pous, Maria
    Garcia-Delpech, Salvador
    Salom, David
    Diaz-Llopis, Manuel
    JOURNAL OF OPHTHALMOLOGY, 2011, 2011
  • [48] Double-Masked Trial Demonstrates Superiority Of Combined Ranibizumab Plus Laser Versus Laser In Patients With Diabetic Macular Edema With Or Without Proliferative Diabetic Retinopathy
    Lohmann, Chris
    Voegeler, Jessica
    Liakopoulos, Sandra
    Wiedemann, Peter
    Spital, Georg
    Lang, Gabriele
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [49] Patients Lost to Follow Up with Proliferative Diabetic Retinopathy & Diabetic Macular Edema
    Sami, Mohammed Abdul
    Bomdica, Prithvi
    Chaturvedi, Vivek
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
  • [50] Baseline Diabetic Retinopathy Severity and Time to Diabetic Macular Edema Resolution with Ranibizumab Treatment: A Meta-Analysis
    Talcott, Katherine E.
    Valentim, Carolina C. S.
    Hill, Lauren
    Stoilov, Ivaylo
    Singh, Rishi P.
    OPHTHALMOLOGY, 2023, 130 (08) : 780 - 780
12345